(Q67921988)
Statements
Phase II study of a 21-day continuous infusion schedule with epirubicin in metastatic colorectal cancer (English)
J Greidanus
P H Willemse
D T Sleijfer
N H Mulder
R C Verschueren
scientific article published on 01 April 1988